Medications

FDA approves cablivi for rare blood-clotting disorder

(HealthDay)—Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Diseases, Conditions, Syndromes

Why your kid's strep throat keeps coming back

Each year, some 600 million people around the world come down with strep throat. But for some children (and their parents) it's more than an occasional misery. It's a recurring nightmare. Yet, it was unclear why some kids ...

Cancer

The role of immune cells in the formation of metastases

Tumor cells use a certain type of immune cell, so-called neutrophils, to enhance their ability to form metastases. Scientists from the University of Basel and the University Hospital of Basel have deciphered the mechanisms ...

Diseases, Conditions, Syndromes

Review finds antibiotic development increased, but insufficient

While the pipeline of new antibiotics has improved over the past six years, momentum in the development of new infection-fighting agents remains inadequate and could take a significant downturn without new incentives, a report ...

page 5 from 23